CytomX Therapeutics, Inc. (CTMX)

NASDAQ: CTMX · Real-Time Price · USD

3.610

-0.170 (-4.50%)

At close: May 15, 2026, 4:00 PM EDT

3.619

+0.009 (0.24%)

After-hours: May 15, 2026, 7:49 PM EDT

CytomX Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	28.83	12.67	38.05	17.17	193.65	205.53
Short-Term Investments	317.88	124.39	62.57	157.34	-	99.7
Cash & Short-Term Investments	346.71	137.05	100.62	174.51	193.65	305.23
Cash Growth	334.00%	36.20%	-42.34%	-9.88%	-36.55%	-3.45%
Accounts Receivable	0.65	2.01	3.1	3.43	35.99	0.79
Other Current Assets	5.74	4.86	3.58	5	7.47	4.29
Total Current Assets	353.1	143.92	107.31	182.94	237.1	310.3
Net Property, Plant & Equipment	3.35	4.7	10.6	16.18	21.02	25.32
Other Intangible Assets	0.4	0.44	0.58	0.73	0.88	1.02
Goodwill	0.95	0.95	0.95	0.95	0.95	0.95
Other Long-Term Assets	1.56	1.56	1.09	1	0.94	1.82
Total Assets	359.36	151.57	120.53	201.79	260.89	339.41
Accounts Payable	1.37	1.3	1.09	1.46	2.81	2.82
Accrued Expenses	11.92	14.2	12.34	17.6	24.45	34.24
Current Portion of Leases	2.86	4.24	5.15	4.59	4.08	-
Unearned Revenue	17.88	26.88	67.2	132.27	121.27	40.82
Total Current Liabilities	34.02	46.62	85.77	155.91	152.61	77.87
Long-Term Leases	-	-	4.24	9.39	13.98	18.06
Other Long-Term Liabilities	5.39	5.94	30.98	83.94	180.06	243.94
Total Long-Term Liabilities	5.39	5.94	35.22	93.33	194.03	262
Total Liabilities	39.41	52.56	120.99	249.24	346.64	339.87
Common Stock	0	0	0	0	0	0
Additional Paid-in Capital	1,050	810.84	691.1	675.91	637.12	623.34
Accumulated Other Comprehensive Income	0.1	0.11	0.03	0.1	0.01	-0.24
Retained Earnings	-730.2	-711.95	-691.58	-723.45	-722.88	-623.56
Shareholders' Equity	319.94	99.01	-0.46	-47.45	-85.75	-0.46
Total Liabilities & Equity	359.36	151.57	120.53	201.79	260.89	339.41
Total Debt	2.86	4.24	9.39	13.97	18.06	18.06
Net Cash (Debt)	343.85	132.81	91.24	160.54	175.59	287.17
Net Cash Growth	158.90%	45.57%	-43.17%	-8.58%	-38.85%	-2.47%
Net Cash Per Share	2.16	0.96	1.08	2.17	2.67	4.48
Book Value	319.94	99.01	-0.46	-47.45	-85.75	-0.46
Book Value Per Share	2.01	0.72	-0.01	-0.64	-1.30	-0.01
Tangible Book Value	318.59	97.62	-1.99	-49.13	-87.58	-2.43
Tangible Book Value Per Share	2.00	0.71	-0.02	-0.67	-1.33	-0.04

Updated May 7, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q